South Africa: SA holds key to 3x5 success, says Lancet

Lack of financial resources, staff, and commitment from key countries, including South Africa, may hamper the World Health Organisation's goal to provide life-long antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005. An Editorial in this week's issue of the The Lancet states that though progress has been made with 720 000 people in developing countries receiving antiretroviral treatment and three times the target number of outlets providing anti-retrovirals, the financial resources allocated to 3 by 5 are below what are needed (US$ 163 million vs 174 million), and the number of WHO staff deployed to the initiative is well below what it should be (112 vs 400).